aredia vial inj
novartis - pamidronate - inj - 60mg(lypholised) - vial
aredia
novartis new zealand ltd - disodium pamidronate pentahydrate 3 mg/ml - solution for infusion - 15mg/5ml - active: disodium pamidronate pentahydrate 3 mg/ml
aredia 30 mg
novartis pharma services ag - pamidronate disodium 30 mg/vial - powder for solution for infusion - pamidronic acid - treatment of: tumor induced hypercalcaemia, bone metastases and multiple myeloma. for the treatment of paget's disease of bone.
aredia 90 mg
novartis pharma services ag - pamidronate disodium 90 mg/vial - powder for solution for infusion - bisphosphonates - tumor induced hypercalcaemia, bone metastases and multiple myeloma. for the treatment of paget's disease of bone.
aredia liq inj 3mg/ml liquid
geigy pharmaceuticals, ciba-geigy canada ltd. - pamidronate disodium - liquid - 3mg - pamidronate disodium 3mg - bone resorption inhibitors
aredia dry powder 90mg powder and solvent for solution for infusion vials
novartis pharmaceuticals uk ltd - pamidronate disodium - powder and solvent for solution for infusion - 90mg
aredia dry powder 15mg powder and solvent for solution for infusion vials
novartis pharmaceuticals uk ltd - pamidronate disodium - powder and solvent for solution for infusion - 15mg
aredia dry powder 30mg powder and solvent for solution for infusion vials
novartis pharmaceuticals uk ltd - pamidronate disodium - powder and solvent for solution for infusion - 30mg
pamidronate disodium for injection solution
fresenius kabi canada ltd - pamidronate disodium - solution - 3mg - pamidronate disodium 3mg - bone resorption inhibitors
pamidronate disodium for injection solution
fresenius kabi canada ltd - pamidronate disodium - solution - 6mg - pamidronate disodium 6mg - bone resorption inhibitors